SC
Sai Chand Yarra
About Sai Chand Yarra
Data last updated:
Sai Chand Yarra is a Director at Spyro Pharmaceuticals Private Limited (since 2021). The company operates in Home Appliances. Spyro Pharmaceuticals Private Limited reported revenue of ₹23.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Mar 2021 | 2021 | ₹23.7 Lakh (FY 2025) | Active |
Board colleagues of Sai Chand Yarra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gopi Krishna Cheemaladinne | 09097497 | Spyro Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sai Chand Yarra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sai Chand Yarra
Sai Chand Yarra currently holds 1 directorship: Spyro Pharmaceuticals Private Limited (Director, since 09 Mar 2021, revenue ₹23.7 Lakh (FY 2025)).
Sai Chand Yarra was first appointed on 09 Mar 2021 as Director at Spyro Pharmaceuticals Private Limited.
The current boards of Sai Chand Yarra's companies include Gopi Krishna Cheemaladinne (Spyro Pharmaceuticals Private Limited).